Aspirin and migraines
This article was originally published in The Tan Sheet
Executive Summary
Acetysalicylic acid is as effective as the Rx medication sumatriptan in relieving both migraine headaches and their symptoms, according to two studies presented in association with the Aspirin Award 2003 meeting in Fiuggi, Italy, Sept. 12. Approximately 312 patients were randomized to take two tablets of Bayer's effervescentAspirin Migraine (1,000 mg ASA), 50 mg sumatriptan, 400 mg ibuprofen or placebo. After two hours, "headaches were less severe or had disappeared altogether" in 52.2% of patients taking aspirin, Bayer states. Ibuprofen and sumatriptan both demonstrated similar effects. The second study found that two hours after administration, almost 44% of patients in the aspirin arm "were free of accompanying symptoms." Bayer was given the go-ahead to market Aspirin Migraine containing 500 mg ASA per tablet in October 2001, but has yet to market the product (1"The Tan Sheet" Nov. 5, 2001, p. 12)...
You may also be interested in...
Bayer Aspirin Migraine Gets FDA Nod; Midol May Be On Deck
Bayer is expanding the scope of its eponymous aspirin brand from heart attack and stroke prevention to migraine pain
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.